Bulletin
Investor Alert

London Markets Open in:

Novartis AG ADR

NYS: NVS

GO
/marketstate/country/us

After Hours

NVS
/zigman2/quotes/203243705/composite

$

95.78

Change

-0.51 -0.53%

Volume

Volume 4,418

Feb 20, 2020, 4:43 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203243705/composite

Previous close

$ 97.22

$ 96.29

Change

-0.93 -0.96%

Day low

Day high

$95.88

$97.09

Open
Open: 97.05

52 week low

52 week high

$74.97

$99.84

Open

Market cap

$218.10B

Average volume

1.68M

P/E ratio

18.98

Rev. per Employee

$415,614

EPS

5.07

Dividend

3.04

Div yield

2.05%

Ex dividend date

3/3/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nvs

MarketWatch News on NVS

  1. Where to Find International Dividend Stocks Now

    2:48 p.m. Jan. 31, 2020

    - Lawrence C. Strauss

  2. Biogen Stock Gets a Lift From Strong Earnings Report

    9:32 a.m. Jan. 30, 2020

    - Josh Nathan-Kazis

  3. Novartis Stock Is Rising as Earnings Inch Past Forecasts

    9:05 a.m. Jan. 29, 2020

    - Josh Nathan-Kazis

  4. Tesla, Apple, Boeing, Amazon, and Other Stocks to Watch This Week

    4:35 p.m. Jan. 27, 2020

    - Nicholas Jasinski

  5. Where to Find Yield in Challenging Markets

    8:30 p.m. Jan. 3, 2020

    - Andrew Bary

  6. The Biotech Sector Is Roaring Into 2020. Here’s Why.

    5:30 a.m. Dec. 27, 2019

    - Josh Nathan-Kazis

  7. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nvs

Other News on NVS

  1. NASH: The Second Wave

    6:29 p.m. Feb. 20, 2020

    - Seeking Alpha

  2. Intellia (NTLA) to Report Q4 Earnings: What's in Store?

    10:53 a.m. Feb. 20, 2020

    - Zacks.com

  3. Imara Files First Statement For U.S. IPO

    12:15 p.m. Feb. 19, 2020

    - Seeking Alpha

  4. Tracking David Einhorn's Portfolio - Q4 2019 Update

    8:53 a.m. Feb. 19, 2020

    - Seeking Alpha

  5. Glaxo Underperforms Industry in a Year: What's in Store?

    10:13 a.m. Feb. 18, 2020

    - Zacks.com

  6. Risks Remain, but Amarin Stock Is a Buy at Today’s Prices

    11:41 a.m. Feb. 14, 2020

    - InvestorPlace.com

  7. AstraZeneca's (AZN) Q4 Earnings and Sales Miss Estimates

    9:21 a.m. Feb. 14, 2020

    - Zacks.com

  8. Maersk Names Patrick Jany CFO

    4:32 p.m. Feb. 12, 2020

    - Nina Trentmann

  9. Pfizer's Xtandi Improves OS Rate in Prostate Cancer Study

    11:10 a.m. Feb. 12, 2020

    - Zacks.com

  10. Buy AbbVie for its Growth Prospects, Yield and Low Valuation

    9:30 a.m. Feb. 12, 2020

    - GuruFocus.com

  11. AbbVie: $100 Next

    2:09 p.m. Feb. 11, 2020

    - Seeking Alpha

  12. Lilly Reports Disappointing Data on Alzheimer's Candidate

    9:12 a.m. Feb. 11, 2020

    - Zacks.com

  13. Gilead's BLA for CAR T Cell Therapy Gets FDA Acceptance

    9:12 a.m. Feb. 11, 2020

    - Zacks.com

  14. Loading more headlines...
/news/pressrelease/company/us/nvs

Press Releases on NVS

  1. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.